Long non-coding antisense RNA HYOU1-AS is essential to human breast cancer development through competitive binding

Aixin Hao1, Yu Wang1, Xiao Zhang1

  • 1Key Laboratory of Saline-alkali Vegetation Ecology Restoration, Ministry of Education, College of Life Science, Northeast Forestry University, Harbin 150040, China.

Insights

Triple negative breast cancer (TNBC) progression is promoted by the long noncoding RNA HYOU1-AS. This lncRNA upregulates the HYOU1 gene, impacting cell proliferation and migration, and is linked to poor patient outcomes.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Triple negative breast cancer (TNBC) presents a poor prognosis due to a lack of effective biomarkers and therapeutic targets.
  • Long noncoding RNAs (lncRNAs) are increasingly implicated in cancer progression, but their specific roles in TNBC remain largely uncharacterized.
  • Understanding lncRNA functions is crucial for developing novel therapeutic strategies against TNBC.

Purpose of the Study:

  • To identify novel lncRNAs involved in TNBC pathogenesis.
  • To elucidate the functional role and regulatory mechanism of a specific lncRNA, HYOU1-AS, in TNBC.
  • To investigate the correlation between HYOU1-AS, its target gene HYOU1, and clinical outcomes in breast cancer patients.

Main Methods:

  • lncRNA microarray analysis was performed on TNBC samples and matched normal tissues.
  • HYOU1-AS expression and localization were analyzed in TNBC cells.
  • Functional assays included HYOU1-AS knockdown in TNBC cells, xenograft tumor formation studies in nude mice, and mechanistic studies involving RNA-binding proteins.
  • TCGA database analysis was used to correlate HYOU1 levels with patient outcomes.

Main Results:

  • A novel antisense lncRNA, HYOU1-AS, was identified and found to be highly expressed in the nucleus of TNBC cells.
  • Knockdown of HYOU1-AS inhibited TNBC cell proliferation, migration, and xenograft tumor growth.
  • HYOU1-AS was shown to promote HYOU1 expression by competitively binding to hnRNPA1, thereby relieving post-transcriptional inhibition.
  • Elevated HYOU1 levels correlated with poorer clinical outcomes in breast cancer patients.

Conclusions:

  • The lncRNA HYOU1-AS acts as a driver of TNBC progression by upregulating the proliferative gene HYOU1.
  • HYOU1-AS represents a potential diagnostic biomarker and therapeutic target for triple negative breast cancer.
  • Targeting the HYOU1-AS/hnRNPA1/HYOU1 axis may offer a novel therapeutic strategy for TNBC treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.8K